AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 1 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,339 | -85.2% | 1,175 | -88.1% | 0.00% | – |
Q2 2023 | $9,030 | +69361.5% | 9,869 | -56.9% | 0.00% | – |
Q1 2023 | $13 | +30.0% | 22,896 | +33.0% | 0.00% | – |
Q4 2022 | $10 | -99.9% | 17,211 | -54.5% | 0.00% | – |
Q3 2022 | $12,000 | -14.3% | 37,823 | -4.1% | 0.00% | – |
Q2 2022 | $14,000 | -65.9% | 39,433 | -30.9% | 0.00% | – |
Q1 2022 | $41,000 | -76.7% | 57,058 | -26.6% | 0.00% | -100.0% |
Q4 2021 | $176,000 | +85.3% | 77,782 | +135.6% | 0.00% | +50.0% |
Q3 2021 | $95,000 | +58.3% | 33,009 | +108.0% | 0.00% | 0.0% |
Q2 2021 | $60,000 | -14.3% | 15,867 | -23.7% | 0.00% | +100.0% |
Q1 2021 | $70,000 | +84.2% | 20,804 | +50.6% | 0.00% | 0.0% |
Q4 2020 | $38,000 | -91.0% | 13,817 | -91.8% | 0.00% | -80.0% |
Q3 2020 | $422,000 | +11.3% | 168,320 | +502.6% | 0.01% | -68.8% |
Q2 2020 | $379,000 | +37800.0% | 27,934 | +27834.0% | 0.02% | – |
Q1 2020 | $1,000 | 0.0% | 100 | -20.0% | 0.00% | – |
Q4 2019 | $1,000 | -96.7% | 125 | -98.4% | 0.00% | -100.0% |
Q3 2019 | $30,000 | +900.0% | 7,767 | +1901.8% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 388 | -22.7% | 0.00% | – |
Q4 2018 | $3,000 | -89.3% | 502 | -82.8% | 0.00% | -100.0% |
Q1 2018 | $28,000 | +64.7% | 2,920 | +148.3% | 0.00% | 0.0% |
Q4 2017 | $17,000 | -41.4% | 1,176 | -20.2% | 0.00% | 0.0% |
Q3 2017 | $29,000 | -14.7% | 1,474 | -37.6% | 0.00% | -50.0% |
Q2 2017 | $34,000 | +112.5% | 2,364 | +58.3% | 0.00% | +100.0% |
Q4 2016 | $16,000 | +100.0% | 1,493 | +69.5% | 0.00% | +100.0% |
Q3 2016 | $8,000 | +14.3% | 881 | -1.9% | 0.00% | 0.0% |
Q2 2016 | $7,000 | -68.2% | 898 | -63.6% | 0.00% | -66.7% |
Q1 2016 | $22,000 | +15.8% | 2,469 | +64.6% | 0.00% | 0.0% |
Q4 2015 | $19,000 | -34.5% | 1,500 | -50.5% | 0.00% | 0.0% |
Q3 2015 | $29,000 | +81.2% | 3,031 | +109.6% | 0.00% | +50.0% |
Q1 2015 | $16,000 | +23.1% | 1,446 | +24.8% | 0.00% | +100.0% |
Q4 2014 | $13,000 | – | 1,159 | – | 0.00% | – |
Q3 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2014 | $46,000 | – | 1,645 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
Ergoteles LLC | 849,000 | $300,000 | 0.01% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |